ArticleCancer letters2026

Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98].

Katsuya Nagaoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.